Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Super-Affinity Antibody

Anti-Human CD223/LAG3 Antibody (SAA0073)

Catalog #:   FHD30420 Specific References (29) DATASHEET
Host species: Human
Isotype: IgG4, kappa
Applications: FCM
Accession: P18627
Overview

Catalog No.

FHD30420

Species reactivity

Human

Host species

Human

Isotype

IgG4, kappa

Clonality

Monoclonal

Conjugation

Unconjugated

Target

FDC, LAG3, Lymphocyte activation gene 3 protein, CD223, sLAG-3, LAG-3

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P18627

Applications

FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

SAA0073

Data Image
References

CD200R activation on naïve T cells by B cells induces suppressive activity of T cells via IL-24., PMID:38780647

Valrubicin-loaded immunoliposomes for specific vesicle-mediated cell death in the treatment of hematological cancers., PMID:38734740

Clinical Significance of Soluble LAG-3 (sLAG-3) in Patients With Cervical Cancer Determined via Enzyme-Linked Immunosorbent Assay With Monoclonal Antibodies., PMID:37968933

LAG-3 transcriptomic expression patterns across malignancies: Implications for precision immunotherapeutics., PMID:37132280

Suppression of Streptococcosis and Modulation of the Gut Bacteriome in Nile Tilapia (Oreochromis niloticus) by the Marine Sediment Bacteria Bacillus haynesii and Advenella mimigardefordensis., PMID:36453920

Epitope Mapping of Therapeutic Antibodies Targeting Human LAG3., PMID:36104110

Research Progress Concerning Dual Blockade of Lymphocyte-Activation Gene 3 and Programmed Death-1/Programmed Death-1 Ligand-1 Blockade in Cancer Immunotherapy: Preclinical and Clinical Evidence of This Potentially More Effective Immunotherapy Strategy., PMID:33488573

Development of a 43 color panel for the characterization of conventional and unconventional T-cell subsets, B cells, NK cells, monocytes, dendritic cells, and innate lymphoid cells using spectral flow cytometry., PMID:33336868

[Next generation of anti-immune checkpoints antibodies]., PMID:31903901

Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation., PMID:30792213

Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer., PMID:30179225

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells., PMID:29553498

Co-inhibitory profile and cytotoxicity of CD57+ PD-1- T cells in end-stage renal disease patients., PMID:29027667

LAG3 (CD223) as a cancer immunotherapy target., PMID:28258692

Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity., PMID:25941596

Prenatal cadmium exposure alters postnatal immune cell development and function., PMID:22521604

MHC class II engagement by its ligand LAG-3 (CD223) contributes to melanoma resistance to apoptosis., PMID:21441454

Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates., PMID:21352204

Soluble pig lymphocyte activation gene-3 (LAG-3; CD223) inhibits human-to-pig xenogeneic mixed lymphocyte reaction., PMID:19834647

Depletion of LAG-3 positive cells in cardiac allograft reveals their role in rejection and tolerance., PMID:18091527

IMP321 (sLAG-3), an immunopotentiator for T cell responses against a HBsAg antigen in healthy adults: a single blind randomised controlled phase I study., PMID:17394654

Soluble CD30 and lymphocyte activation gene-3 (CD223), as potential serological markers of T helper-type cytokine response induced by acellular pertussis vaccine., PMID:16569347

Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells., PMID:15971272

The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells., PMID:15885122

LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors., PMID:15720438

Negative regulation of T cell homeostasis by lymphocyte activation gene-3 (CD223)., PMID:15634887

MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)., PMID:12775570

LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice., PMID:12750275

Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)., PMID:12209638

Datasheet
$ 225
Product specifications
50 μg 225 100 μg 372

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human CD223/LAG3 Antibody (SAA0073) [FHD30420]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only